October 26, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Amazon, Amazon entering the pharmacy market, Amazon's pharmacy market intentions, CBX, Drug Channels Institute, Greg Lipman, Jeffrey Woldt, pharmacy wholesale licenses, prescription drug business
CDR Blog
Amazon has quietly received approvals for pharmacy wholesale licenses from at least a dozen state pharmacy boards, the St. Louis Post-Dispatch reported Thursday. Those states are Alabama, Arizona, Connecticut, Idaho, Louisiana, Michigan, New Hampshire, New Jersey, Nevada, North Dakota, Oregon and Tennessee. Another pharmacy distribution license application is pending in Maine, the report said. Amazon
June 5, 2017 by Greg Jacobson and Chain Drug Review
Adam Fein, Amazon.com, Drug Channels Institute, Keith Anderson, Mark Lyons, pharmacy benefits, pharmacy industry, Premera Blue Cross, Profitero, retail pharmacy market
2017, Issue 06-05-2017, Issues, News
NEW YORK — The retail pharmacy market may soon face an unwelcome challenge from e-commerce giant Amazon.com Inc. According to a recent report by CNBC, the company has hired a number of people from the pharmacy industry and is conducting a search for a general manager to lead a team and create a strategy. The
May 23, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Amazon, Drug Channels, Drug Channels Institute, online retailing
CDR Blog
Amazon’s success as a pioneer of online retailing is unquestioned, and it continues to be a disruptor to brick-and-mortar retailers (most recently, grocery retailers). But the e-tail giant’s alternatives in the pharmacy space — which CNBC reported it has targeted — aren’t so clear cut, according to pharmacy supply chain expert Adam Fein. “I would
April 24, 2017 by Chain Drug Review
Adam Fein, Affordable Care Act, American Health Care Act, Bob Kirby, CFRA, chain drug industry, chain drug stores, David Silverman, Drug Channels Institute, Fitch Ratings, Fred's, health insurance coverage, Joseph Agnese, Pembroke Consulting, Walgreens-Rite Aid merger
2017, Business, Featured Articles, Issue 04-24-2017, Issues, Leading Headlines, News, Retail News
NEW YORK — Entering the second quarter of 2017, the chain drug industry was awaiting answers to a couple of big, lingering questions. First, what will the chain drug landscape look like? A significant change in the field of players is likely in store pending antitrust clearance of Walgreens Boots Alliance Inc.’s (WBA’s) deal to
February 8, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Drug Channels Institute, pharmaceutical supply chain, pharmacy industry, specialty drugs, specialty pharmacy
CDR Blog
The rapid growth of the specialty pharmacy sector, fueled by high-priced specialty drugs, remains one of the leading story lines in the pharmacy industry. Compared with the retail pharmacy arena, the field of players in the specialty Rx market has yet to shake out. But pharmaceutical supply chain and economics expert Adam Fein, CEO of
November 11, 2016 by CDR Blog and Chain Drug Review
Adam Fein, CVS Caremark, CVS Health, CVS Pharmacy, Drug Channels, Drug Channels Institute, Maintenance Choice, OptumRx, Pembroke Consulting, pharmacy industry, Prime Therapeutics, Tricare, Walgreens Boots Alliance, WBA
CDR Blog
CVS Health’s scaled-back 2017 guidance, given in its third-quarter report this week, spotlights an intensifying competitive battle with rival Walgreens Boots Alliance. CVS reported that for fiscal 2017 it expects to lose over 40 million retail prescriptions due to marketplace changes, notably narrower retail pharmacy networks excluding CVS Pharmacy drug stores. The announcement sent CVS
June 6, 2016 by Geoff Walden and Chain Drug Review
Adam Fein, Drug Channels Institute, generic drug sourcing, George Riedl, Mark Walchirk, McKesson, Pembroke Consulting, Walmart
2016, Issue 06-06-2016, Issues, News
BENTONVILLE, Ark. — Walmart has become the latest retailer to ally with a pharmaceutical distributor for generic drug sourcing. The mass merchandiser’s partnership with McKesson Corp. includes an expanded long-term distribution pact and will add scale and value for both companies, they said. The agreement positions Walmart and McKesson to compete with partnerships between Walgreens
May 17, 2016 by CDR Blog
Adam Fein, AmerisourceBergen, Cardinal Health, Drug Channels, Drug Channels Institute, McKesson, Pembroke Consultin, Rite Aid, Walgreens, Walmart
CDR Blog
The expanded distribution agreement between McKesson and Walmart not only brings McKesson a generic drug customer it had been pursuing, but it also “finalizes an intriguing industry channel alignment,” according to pharmacy supply chain expert Adam Fein, president of Pembroke Consulting. In a posting Tuesday on his Drug Channels blog, Fein noted that Walmart was
April 18, 2016 by Chain Drug Review
Adam Fein, chain drug stores, Drug Channels Institute, drug wholesalers, Joseph Agnese, Pembroke Consulting, pharmacy industry, pharmacy supply chain, retail pharmacy, S&P Capital IQ
2016, Business, Featured Articles, Issue 04-18-2016, Issues, Leading Headlines, News, Retail News
NEW YORK — Going forward, chain drug stores can bank on the same underlying trends that have fueled the retail pharmacy business in recent years. But the industry as they’ve known it won’t look quite the same. Retailer consolidation, changes in drug purchasing and the influx of specialty drugs are reshaping the competitive arena, industry
April 4, 2016 by Geoff Walden and Chain Drug Review
Adam Fein, Alex Gourlay, Drug Channels Institute, Larry Renfro, OptumRx, PBMs, Pembroke Consulting, pharmacy care, Walgreens, Walgreens Boots Alliance
2016, Issue 04-04-2016, Issues, News
DEERFIELD, Ill. — Walgreens is partnering with OptumRx to create a new pharmacy benefit to meet consumers’ changing prescription drug needs and help employers, health plans and their members achieve better health outcomes and greater cost savings. OptumRx is UnitedHealth Group’s freestanding pharmacy care services business, managing more than a billion prescriptions annually. Through a
March 25, 2016 by CDR Blog
Adam Fein, AmerisourceBergen, Drug Channels Institute, OptumRx, Pembroke Consulting, Rite Aid, Walgreens Boots Alliance, WBA
CDR Blog
The presence of Walgreens Boots Alliance (WBA) across the pharmacy care sector continues to broaden and deepen. Over two days earlier this month, WBA unveiled an integrated pharmacy offering with PBM OptumRx and then announced that it’s boosting its equity stake in drug distributor AmerisourceBergen. The highlight of the offering with OptumRx is that members
February 19, 2016 by CDR Blog
Adam Fein, Drug Channels Institute, Pembroke Consultin, retail clinic, walk-in clinics
CDR Blog
Though the number of walk-in clinics in retail pharmacies has surged over the years, 2016 stands to see slow growth, says Adam Fein, CEO of the Drug Channels Institute. This week, Fein posted an overview of the retail clinic arena on his Drug Channels blog, including a chart listing the top players — CVS (MinuteClinic),
February 2, 2016 by CDR Blog
Adam Fein, Drug Channels Institute, Pembroke Consulting, pharmacy industry, specialty drugs
CDR Blog
Pharmaceutical supply chain and economics expert Adam Fein, CEO of the Drug Channels Institute, says specialty drugs continue to hoist pharmacy industry sales, according to his firm’s latest analysis. “We project that the pharmacy industry’s revenues will exceed $483 billion in 2020,” stated Fein, author of the 2016 Economic Report on Retail, Mail, and Specialty Pharmacies
November 9, 2015 by Geoff Walden and Chain Drug Review
Adam Fein, Alex Gourlay, chain drug retailing, CVS/pharmacy, Drug Channels Institute, George Fairweather, John Standley, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
2015, Issue 11-09-2015, Issues, News
DEERFIELD, Ill. — The consolidation of chain drug retailing climaxed last month with Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. In the largest outright purchase of a chain in the industry’s history, WBA agreed to acquire Rite Aid for $9 per share, or $17.2 billion, including debt. The price represents a premium